{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:41:59Z","timestamp":1789897319845,"version":"4.0.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"17","license":[{"start":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T00:00:00Z","timestamp":1545609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Claret Medical, Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The role of cerebral embolic protection (CEP) in transcatheter aortic valve replacement (TAVR) remains controversial. Randomized trials have not been powered to demonstrate a reduction in stroke rates. The aim of this patient level pooled analysis was to validate the impact of the dual-filter CEP device (Claret Medical Inc., CA, USA) on peri-procedural stroke in a large number of TAVR patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Patients from the SENTINEL US IDE trial were combined with the CLEAN-TAVI and SENTINEL-Ulm study in a patient level pooled analysis (N\u2009=\u20091306). Propensity score matching was performed to adjust for possible confounders. The primary endpoint was procedural stroke within 72\u2009h post-TAVR according to Valve Academic Research Consortium-2 criteria. The secondary endpoint was the combination of all-cause mortality or all-stroke within 72\u2009h after TAVR. In the propensity-matched population, 533 patients underwent TAVR without CEP and 533 patients underwent TAVR with CEP. TAVR patients without vs. with CEP were similar with respect to baseline characteristics, procedural approach, or valve type. In patients undergoing TAVR with dual-filter CEP, procedural all-stroke was significantly lower compared with unprotected procedures [1.88% vs. 5.44%, odds ratio 0.35, 95% confidence interval (CI) 0.17\u20130.72, relative risk reduction 65%, P\u2009=\u20090.0028]. In addition, all-cause mortality and all-stroke were significantly lower (2.06% vs. 6.00%, odds ratio 0.34, 95% CI 0.17\u20130.68, relative risk reduction 66%, P\u2009=\u20090.0013).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our findings suggest that TAVR with the dual-filter CEP device is associated with a significant lower rate of peri-procedural stroke compared with unprotected procedures. However, randomized trials are still needed to clarify this issue.<\/jats:p>\n                  <jats:p\/>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehy847","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T20:12:51Z","timestamp":1544040771000},"page":"1334-1340","source":"Crossref","is-referenced-by-count":83,"title":["Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis"],"prefix":"10.1093","volume":"40","author":[{"given":"Julia","family":"Seeger","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II \u2013 Cardiology, University of Ulm, Albert-Einstein-Allee 23, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir R","family":"Kapadia","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, Department of Cardiology, Euclid Ave, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susheel","family":"Kodali","sequence":"additional","affiliation":[{"name":"Columbia University Medical Centre, 161 Fort Washington Ave, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Linke","sequence":"additional","affiliation":[{"name":"Herzzentrum Dresden Universit\u00e4tsklinik, Fetscherstra\u00dfe 76, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"W\u00f6hrle","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II \u2013 Cardiology, University of Ulm, Albert-Einstein-Allee 23, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Haussig","sequence":"additional","affiliation":[{"name":"Herzzentrum Dresden Universit\u00e4tsklinik, Fetscherstra\u00dfe 76, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Makkar","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Centre, 8631 W 3rd St, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[{"name":"Mount Sinai School of Medicine, 1190 5th Avenue, 1 South, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Rottbauer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II \u2013 Cardiology, University of Ulm, Albert-Einstein-Allee 23, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Leon","sequence":"additional","affiliation":[{"name":"Columbia University Medical Centre, 161 Fort Washington Ave, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,24]]},"reference":[{"key":"2022102605422529800_ehy847-B1","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1212\/WNL.57.7.1222","article-title":"Silent MRI infarcts and the risk of future stroke: the cardiovascular health study","volume":"57","author":"Bernick","year":"2001","journal-title":"Neurology"},{"key":"2022102605422529800_ehy847-B2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/heartjnl-2011-300065","article-title":"Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status","volume":"98","author":"Fairbairn","year":"2012","journal-title":"Heart"},{"key":"2022102605422529800_ehy847-B3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1474-4422(07)70170-9","article-title":"Silent brain infarcts: a systematic review","volume":"6","author":"Vermeer","year":"2007","journal-title":"Lancet Neurol"},{"key":"2022102605422529800_ehy847-B4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4244\/EIJV8I1A20","article-title":"Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10, 037 published patients","volume":"8","author":"Eggebrecht","year":"2012","journal-title":"EuroIntervention"},{"key":"2022102605422529800_ehy847-B5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.116.025103","article-title":"SOURCE 3 registry: design and 30-day results of the European postapproval registry of the latest generation of the SAPIEN 3 transcatheter heart valve","volume":"135","author":"Wendler","year":"2017","journal-title":"Circulation"},{"key":"2022102605422529800_ehy847-B6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jama.2016.10302","article-title":"Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial","volume":"316","author":"Haussig","year":"2016","journal-title":"JAMA"},{"key":"2022102605422529800_ehy847-B7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jacc.2016.10.023","article-title":"Protection against cerebral embolism during transcatheter aortic valve replacement","volume":"69","author":"Kapadia","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022102605422529800_ehy847-B8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ahj.2017.06.007","article-title":"Overview of the 2017 US Food and Drug Administration circulatory system devices panel meeting on the Sentinel cerebral protection system","volume":"192","author":"Rogers","year":"2017","journal-title":"Am Heart J"},{"key":"2022102605422529800_ehy847-B9","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jcin.2017.07.032","article-title":"Routine use of embolic protection during transcatheter aortic valve replacement","volume":"10","author":"Kapadia","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102605422529800_ehy847-B10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4244\/EIJV12I4A84","article-title":"Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial","volume":"12","author":"Van Mieghem","year":"2016","journal-title":"EuroIntervention"},{"key":"2022102605422529800_ehy847-B11","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document","volume":"60","author":"Kappetein","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2022102605422529800_ehy847-B12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijcard.2016.06.143","article-title":"Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: a systematic review and meta-analysis","volume":"221","author":"Pagnesi","year":"2016","journal-title":"Int J Cardiol"},{"key":"2022102605422529800_ehy847-B13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jacc.2016.10.036","article-title":"Cerebral embolic protection during transcatheter aortic valve replacement. A disconnect between logic and data?","volume":"69","author":"Latib","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022102605422529800_ehy847-B14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jacc.2016.12.002","article-title":"Cerebral embolic protection during TAVR: a clinical event meta-analysis","volume":"69","author":"Giustino","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022102605422529800_ehy847-B15","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.amjcard.2016.08.013","article-title":"Neurologic complications of unprotected transcatheter aortic valve implantation (from the neuro-TAVI trial)","volume":"118","author":"Lansky","year":"2016","journal-title":"Am J Cardiol"},{"key":"2022102605422529800_ehy847-B16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jns.2012.02.021","article-title":"Microembolism, silent brain infarcts and dementia","volume":"322","author":"Goldberg","year":"2012","journal-title":"J Neurol Sci"},{"key":"2022102605422529800_ehy847-B17","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1161\/STROKEAHA.114.005205","article-title":"Persistent cognitive impairment after transient ischemic attack","volume":"45","author":"van Rooij","year":"2014","journal-title":"Stroke"},{"key":"2022102605422529800_ehy847-B18","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa022066","article-title":"Silent brain infarcts and the risk of dementia and cognitive decline","volume":"348","author":"Vermeer","year":"2003","journal-title":"N Engl J Med"},{"key":"2022102605422529800_ehy847-B19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCINTERVENTIONS.112.000429","article-title":"Cognitive trajectory after transcatheter aortic valve implantation","volume":"6","author":"Ghanem","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"2022102605422529800_ehy847-B20","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1161\/STROKEAHA.114.005919","article-title":"Emerging spectra of silent brain infraction","volume":"45","author":"Fanning","year":"2014","journal-title":"Stroke"},{"key":"2022102605422529800_ehy847-B21","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/STROKEAHA.109.570044","article-title":"Association of MRI markers of vascular brain injury with incident stroke mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study","volume":"41","author":"Debette","year":"2010","journal-title":"Stroke"},{"key":"2022102605422529800_ehy847-B22","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.jcin.2017.06.037","article-title":"Cerebral embolic protection during transfemoral aortic valve replacement significantly reduces death and stroke compared with unprotected procedures","volume":"10","author":"Seeger","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102605422529800_ehy847-B23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003551","article-title":"Neurological events following transcatheter aortic valve replacement and their predictors: a report from the CoreValve trials","volume":"9","author":"Kleiman","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"2022102605422529800_ehy847-B24","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"key":"2022102605422529800_ehy847-B25","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jcin.2010.09.008","article-title":"Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging","volume":"3","author":"Arnold","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102605422529800_ehy847-B26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jacc.2010.07.036","article-title":"Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches","volume":"57","author":"Rod\u00e9s-Cabau","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2022102605422529800_ehy847-B27","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/CIRCULATIONAHA.109.855866","article-title":"Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study","volume":"121","author":"Kahlert","year":"2010","journal-title":"Circulation"},{"key":"2022102605422529800_ehy847-B28","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jacc.2009.12.026","article-title":"Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging","volume":"55","author":"Ghanem","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2022102605422529800_ehy847-B29","doi-asserted-by":"crossref","first-page":"O59.","DOI":"10.1186\/1532-429X-15-S1-O59","article-title":"Difference between cerebral embolic events following transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR): a diffusion weighted MRI study","volume":"15","author":"Uddin","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2022102605422529800_ehy847-B30","first-page":"79","article-title":"Cerebral embolization during percutaneous valve implantation does not occur during balloon inflation valvuloplasty: prospective diffusion-weighted brain MRI study","volume":"22","author":"Astarci","year":"2013","journal-title":"J Heart Valve Dis"},{"key":"2022102605422529800_ehy847-B31","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ccd.27323","article-title":"Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement","volume":"91","author":"Van Gils","year":"2018","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/17\/1334\/46634957\/eurheartj_40_17_1334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/17\/1334\/46634957\/eurheartj_40_17_1334.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T05:47:43Z","timestamp":1666763263000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/40\/17\/1334\/5259357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,24]]},"references-count":31,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2018,12,24]]},"published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehy847","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5,1]]},"published":{"date-parts":[[2018,12,24]]}}}